Clinical Study

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

Table 1

Demographic data and endoscopic appearances of the two patient groups.

Characteristics EACM ()EAC ()P value

Age (year) (mean ± SD)47.8 ± 11.652.8 ± 12.80.593
Gender (male/female)45/4746/460.883
Smoking 14141.000
Alcohol consumption20140.254
Previous history of peptic ulcer14190.337
Endoscopic findings 0.964
 Gastritis 3234
 Gastric ulcer 2222
 Duodenal ulcer 3128
 Gastric and duodenal ulcer78

EACM group: 7-day esomeprazole/amoxicillin/clarithromycin/metronidazole therapy; EAC group: 7-day standard esomeprazole/amoxicillin/clarithromycin/triple therapy.